Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 18.87%46.38M | 15.44%39.02M | 29.48%33.8M | 12.01%26.1M | 3.89%23.3M | -3.24%22.43M | 5.74%23.18M | 11.40%21.93M | 66.53%19.68M | -6.74%11.82M |
| Revenue from customers | 19.59%46.75M | 16.06%39.09M | 29.32%33.68M | 11.76%26.05M | 3.89%23.3M | -1.88%22.43M | 7.22%22.86M | 12.91%21.32M | 80.03%18.89M | -17.22%10.49M |
| Other cash income from operating activities | -389.28%-373.77K | -166.85%-76.39K | 99.66%114.27K | --57.23K | ---- | ---- | -46.57%321.92K | -24.29%602.48K | -40.09%795.79K | --1.33M |
| Cash paid | -30.03%-41.12M | -17.19%-31.62M | -41.46%-26.99M | -15.47%-19.08M | 6.32%-16.52M | 12.26%-17.63M | -11.92%-20.1M | -18.58%-17.96M | -97.80%-15.14M | 13.05%-7.66M |
| Payments to suppliers for goods and services | -30.03%-41.12M | -17.19%-31.62M | -41.46%-26.99M | -15.47%-19.08M | 6.32%-16.52M | 12.26%-17.63M | -11.92%-20.1M | -18.58%-17.96M | -97.80%-15.14M | 13.05%-7.66M |
| Direct interest paid | -37.47%-1.3M | -84.93%-942.9K | -32.02%-509.87K | 17.62%-386.21K | 22.10%-468.79K | 2.23%-601.81K | -10.62%-615.55K | -38.17%-556.43K | -87.17%-402.72K | 48.95%-215.17K |
| Direct interest received | -5.53%11.95K | 32.28%12.65K | 12.04%9.56K | --8.54K | ---- | ---- | ---- | ---- | ---- | -50.00%8K |
| Direct tax refund paid | -45.25%-1.05M | 65.65%-719.49K | -313.10%-2.09M | 34.33%-507.03K | -67.78%-772.04K | 44.57%-460.15K | -13.95%-830.16K | 33.28%-728.52K | 11.49%-1.09M | -130.88%-1.23M |
| Operating cash flow | -49.02%2.93M | 36.14%5.74M | -31.34%4.22M | 10.79%6.14M | 48.39%5.54M | 127.97%3.74M | -38.91%1.64M | -11.84%2.68M | 11.82%3.04M | -7.03%2.72M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -30.34%-3.89M | 17.63%-2.99M | -272.34%-3.63M | -20.09%-974.21K | 71.71%-811.25K | -8.89%-2.87M | -252.28%-2.63M | 85.76%-747.53K | -1,430.49%-5.25M | 127.43%394.56K |
| Capital expenditure reported | ---- | ---- | ---- | ---163.37K | ---- | ---- | ---- | 15.17%-422.73K | ---498.32K | ---- |
| Net PPE purchase and sale | -38.56%-414.07K | -93.37%-298.84K | -26.97%-154.55K | -388.92%-121.72K | 12.52%-24.9K | 57.95%-28.46K | 59.23%-67.69K | 57.09%-166.02K | ---386.91K | ---- |
| Net intangibles purchas and sale | 80.39%-33.89K | 89.12%-172.81K | -872.41%-1.59M | 16.24%-163.37K | 33.31%-195.06K | -17.30%-292.5K | ---249.35K | ---- | ---- | ---- |
| Net business purchase and sale | -14.58%-3.09M | -29.79%-2.7M | -362.87%-2.08M | 23.98%-449.5K | 43.82%-591.3K | -140.74%-1.05M | 372.62%2.58M | 137.12%546.69K | 70.66%-1.47M | -137.20%-5.02M |
| Net investment purchase and sale | ---352.5K | ---- | ---- | ---- | ---- | ---- | ---- | -55.80%-422.73K | -103.72%-271.32K | --7.29M |
| Dividends received (cash flow from investment activities) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 43.33%-705.47K | -145.20%-1.24M | 21.99%-507.69K |
| Net other investing changes | ---- | -6.26%184.06K | 181.95%196.36K | ---239.61K | ---- | 69.51%-1.49M | ---4.9M | ---- | -0.66%-1.38M | -199.48%-1.37M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -30.34%-3.89M | 17.63%-2.99M | -272.34%-3.63M | -20.09%-974.21K | 71.71%-811.25K | -8.89%-2.87M | -252.28%-2.63M | 85.76%-747.53K | -1,430.49%-5.25M | 127.43%394.56K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 187.46%2.88M | -1,113.36%-3.29M | 106.36%324.57K | -7.24%-5.11M | -383.78%-4.76M | -403.34%-984.05K | 119.30%324.4K | -207.20%-1.68M | 164.03%1.57M | -125.15%-2.45M |
| Net issuance payments of debt | 335.64%5.51M | -75.47%1.27M | 383.44%5.16M | 36.88%-1.82M | -1,330.90%-2.88M | -77.40%234.24K | 8,073.58%1.04M | -100.35%-13K | 184.42%3.7M | -1,022.74%-4.38M |
| Net common stock issuance | 3,487.16%2.03M | 80.14%-59.83K | -350.19%-301.25K | -83.64%120.41K | 113.91%736.11K | -30.11%344.12K | --492.38K | ---- | 280.44%510.84K | -98.50%-283.11K |
| Cash dividends paid | -18.13%-3.9M | -3.54%-3.3M | -30.22%-3.19M | -42.69%-2.45M | -130.02%-1.72M | 38.04%-746.16K | 27.80%-1.2M | -8.00%-1.67M | -8.59%-1.54M | -0.18%-1.42M |
| Net other financing activities | 68.08%-761.45K | -0.50%-2.39M | -24.02%-2.37M | -6.66%-1.91M | -9.91%-1.79M | ---1.63M | ---- | ---- | -130.15%-1.1M | --3.64M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 187.46%2.88M | -1,113.36%-3.29M | 106.36%324.57K | -7.24%-5.11M | -383.78%-4.76M | -403.34%-984.05K | 119.30%324.4K | -207.20%-1.68M | 164.03%1.57M | -125.15%-2.45M |
| Net cash flow | ||||||||||
| Beginning cash position | -51.32%507.86K | 710.65%1.04M | 95.81%128.7K | -29.70%65.73K | -55.22%93.49K | -76.24%208.79K | 40.77%878.83K | -50.56%624.29K | 112.12%1.26M | 206.71%595.29K |
| Current changes in cash | 456.51%1.91M | -158.54%-535.44K | 1,352.35%914.6K | 326.80%62.97K | 75.92%-27.77K | 82.79%-115.3K | -363.23%-670.04K | 139.87%254.54K | -195.66%-638.46K | 66.37%667.46K |
| End cash Position | 375.87%2.42M | -51.32%507.86K | 710.65%1.04M | 95.81%128.7K | -29.70%65.73K | -55.22%93.49K | -76.24%208.79K | 40.77%878.83K | -50.56%624.29K | 112.12%1.26M |
| Free cash from | -52.96%2.48M | 112.99%5.27M | -56.55%2.47M | 6.95%5.69M | 55.89%5.32M | 158.36%3.42M | -36.88%1.32M | -2.96%2.09M | -20.71%2.16M | -5.59%2.72M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |